- Elite Trade Club
- Posts
- 4 Active stocks to watch closely today 👀
4 Active stocks to watch closely today 👀
Premarket Report
Chris Dinello
December 28, 2023
Good Morning!
It's Chris from Elite Trade Club, here to give you this morning's premarket trading news.
Now, let's get ready to trade!
Before we get started, I want to give you a quick update on our latest featured growth stock.
For November, we picked a promising eCommerce stock with long-term growth prospects that was in excellent position for a potential rebound.
It turned out, our instincts were correct. Since making the pick, shares have continued to push higher.
As I am writing this, shares have gained 18.9% over the past 30 days.
Better yet, momentum appears to still be on its side. Share prices have run into some resistance over the past week, but prices are holding steady in a new trading range.
We just dropped our December stock pick yesterday, and it could produce similar results. Given the Fed’s recent pivot on rates, I’m especially excited about its outlook.
Elite Growth Stocks brings you top stock picks like these every month, plus exclusive analysis from me, Adam, and the rest of the team.
You’ll also get instant access to five bonus research reports that are LOADED with additional stock picks when you sign on.
So, if you’re not already a member, what are you waiting for?
Markets 📈
U.S. indexes maintained their win streak on Wednesday with modest gains across the board.
|
|
Futures are mixed in early trading. S&P 500 contracts are holding close to flat, and Dow contracts are down 0.1%.
Sponsored
Rising interest rates... Skyrocketing inflation... Exploding debt... A looming recession...
It's no wonder Americans are becoming concerned about their savings and investments.
That's why Ben Stein wrote his newest report...
This FREE REPORT shows YOU how you could protect your retirement savings before it's too late.
Get started now to see how you can protect everything you've worked for!
Premarket Highlights 🔎
🏆 Nasdaq’s Dominates NYSE in IPO Race… Again
For the fifth year running, Nasdaq is set to outpace the New York Stock Exchange (NYSE) in the number of initial public offerings (IPOs). This ongoing success underscores a significant shift in one of Wall Street's most iconic rivalries.
💰 IPO Fundraising Figures:
Nasdaq's Haul: IPOs on Nasdaq have accumulated $13.6 billion in 2023.
NYSE's Performance: The NYSE trails with $10.4 billion raised through new listings, as per Dealogic data.
📊 Rivalry Dynamics:
Once recognized as the platform for dot-com companies, Nasdaq has evolved to compete head-to-head with NYSE for major IPOs.
The once-dominant NYSE is witnessing a shift in its status, grappling with Nasdaq's aggressive push for large-scale listings.
🌐 Global Perspective:
Some market experts believe the intense competition between Nasdaq and NYSE has elevated New York's status as a global IPO hub, contrasting with markets like London or Hong Kong, which are often led by a single exchange operator.
🚀 Notable Nasdaq Debuts in 2023:
Arm Holdings [ARM]: The U.K. chip designer's IPO, raising $5.2 billion, marked the largest of the year.
Instacart [CART]: The grocery-delivery service made a significant entry into the public market.
Nextracker [NXT]: A solar-technology provider, also chose Nasdaq for its market debut.
Nasdaq's streak in leading the IPO race not only reflects its strategic growth but also highlights the evolving landscape of capital markets, where traditional lines between exchanges are increasingly blurred.
What to Watch Today 👀
Holiday Trading Week
As I said yesterday, I am anticipating a slow trading week. This week’s schedule for earnings & economic updates is very thin, and most of the country will be in holiday mode until after the New Year holiday on Monday. However, I’m currently seeing above average volume in today’s premarket, so there could be some short-term trade opportunities on the table.
Featured Earnings 💲
Bridgeline Digital [BLIN] ... PM
Economy 🏗
Initial jobless claims [Dec.23] ... 8:30a
Advanced U.S. trade balance in goods [Nov] ... 8:30a
Advanced retail inventories [Nov] ... 8:30a
Advanced wholesale inventories [Nov] ... 8:30a
Pending home sales [Nov] ... 10:00a
Running Hot 🔥
Gainers
Nova Lifestyle [NVFY] >> +145.1%
Next eGO [EGOX] >> +47.8%
CN Energy [CNEY] >> +42.0%
Decliners
Bluejay Diagnostic [BJDX] >> (33.3%)
Spyre Therapeutics [SYRE] >> (18.3%)
Cytosorbents [CTSO] >> (35.5%)
Cingulate [CING] - Last Close: $3.99
This tiny biotech continues to run hot after announcing a clinical update early Wednesday morning.
Details were still scant when I reported this move yesterday, but it has since become obvious that the impetus for the rally was the new clinical data.
Cingulate said it received guidance from the FDA regarding CTX-1301 drug candidate for ADHD.
Based on the updated guidance, Cingulate now expects to submit a new approval application for the drug in the first half of 2025.
CING added 101.5% yesterday, and it’s up another 176.9% in today’s premarket, with nearly 3 million shares traded this morning alone.
My Take: CING’s runaway rally could be attributed to its high short percentage. After all, this clinical update wasn’t THAT great, so there’s a good chance that this rally is overextending itself.
SEALSQ [LAES] - Last Close: $1.15
In an early morning update, the semiconductor company revealed that it has added new capabilities to its post-quantum semiconductor technology.
According to the statement, its new technologies are being specifically designed to withstand cyber attacks and to keep crypto transactions secure.
The company says the technology secures existing blockchain infrastructure and “paves the way for a more secure digital ecosystem.”
Shares of LAES are up 33.1% with more than 12 million shares traded in today’s premarket.
My Take: It’s unclear whether LAES actually has this technology in hand or if they’re simply saying they’re planning on making it. If they don’t even have it yet, I think this move is somewhat overdone.
Microbot Medical [MBOT] - Last Close: $1.32
This morning, the company announced positive results from a GLP pivotal pre-clinical study of its LIBERTY® Endovascular Robotic Surgical System.
In the study, three interventionalist radiologists used the system to perform 96 robotic navigations which were followed by microscopic reviews of tissue.
Microbot said the device passed with flying colors and achieved all study objectives.
“I am very pleased…” said CMO Juan Diaz Cartelle. “This gives us confidence to move forward to the next stage of human clinical studies.”
MBOT is up 49.6% on 2.5 million shares traded in the premarket.
My Take: This could be a big pivot point for MBOT. The stock has been ramming its head against stiff resistance over the past couple of months, but this rally could give it the boost it needs to break through $1.50 per share.
SenesTech [SNES] - Last Close: $0.8625
This morning, analysts at HC Wainwright & Co. maintained a “buy” rating on SNES and slashed its price target on the stock to $3.50 from $4 previously.
Just a few days earlier, analysts at Refinitv/Verus downgraded SNES from “buy” to “hold.”
Despite the downgrades, shares are picking up steam. SNES is up 51.3% over the past ten days, and they’re running hot again today.
SNES is one of this morning’s top movers with a 80.8% gain on nearly 15 million shares traded.
My Take: I have no clue what is going on with SNES. It may have simply reached its natural bottom, and traders are capitalizing on its micro-float with coordinated buying raids.
That's it for today! Thanks for reading, and good luck out there!
Best Regards,
— Chris D.
Elite Trade Club
Text ELITE to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.